Market Overview

62 Biggest Movers From Yesterday

Share:
62 Biggest Movers From Yesterday

Gainers

  • Westwater Resources, Inc. (NASDAQ: WWR) shares surged 87.3% to close at $8.28 on Monday after surging 49% on Friday. The company holds minerals rights for lithium and uranium deposits and strength appears related to momentum in lithium names amid EV battery interest.
  • MyoKardia, Inc. (NASDAQ: MYOK) shares jumped 57.8% to close at $220.34 on Monday after Bristol-Myers Squibb announced a multi-billion dollar deal to buy cardio-focused biopharma Myokardia.
  • Eidos Therapeutics, Inc. (NASDAQ: EIDX) climbed 41.6% to close at $73.51 after the company announced it would be acquired by BridgeBio for $73.26 per share.
  • Enlivex Therapeutics Ltd. (NASDAQ: ENLV) shares gained 38.2% to close at $14.30 after surging around 18% on Friday. Enlivex Therapeutics, last week, announced positive top-line results of an investigator-initiated clinical trial of Allocetra in COVID-19 patients in severe/critical condition.
  • LENSAR, Inc. (NASDAQ: LNSR) surged 35.6% to close at $12.20.
  • ProPhase Labs, Inc. (NASDAQ: PRPH) jumped 33.8% to close at $6.89. ProPhase Labs recently announced plans to explore the acquisition of one or more CLIA accredited labs suitable for COVID-19 and other testing.
  • Piedmont Lithium Limited (NYSE: PLL) shares rose 32.8% to close at $34.66 on continued strength after the company in late September announced it signed a sales agreement with Tesla.
  • CBAK Energy Technology, Inc. (NASDAQ: CBAT) climbed 32.6% to close at $4.15 amid continued volatility in the lithium and EV battery space.
  • Scully Royalty Ltd. (NYSE: SRL) shares gained 26.3% to close at $4.80 after the company issued a corporate update.
  • Axovant Gene Therapies Ltd. (NASDAQ: AXGT) gained 24.6% to close at $5.63. Axovant Gene Therapies, last month, reported development and manufacturing partnership with Viralgen.
  • Humanigen, Inc. (NASDAQ: HGEN) rose 23.3% to close at $12.14. Humanigen, on Friday, issued updates on Lenzilumab in COVID-19 program.
  • SPI Energy Co., Ltd. (NASDAQ: SPI) surged 20.8% to close at $6.86 amid investor hopes of an improvement in President Trump's Health as well as stimulus hopes.
  • Pulse Biosciences, Inc. (NASDAQ: PLSE) surged 19.8% to close at $16.06 after gaining 15% on Friday. Pulse Biosciences, last week, reported FDA Investigational Device Exemption approval and initiation of sebaceous hyperplasia study.
  • Cytokinetics, Incorporated (NASDAQ: CYTK) rose 19.3% to close at $28.61 after the company presented study data at the Heart Failure Society of America annual meeting.
  • Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) gained 19.3% to close at $4.86 after the company announced positive early results from a study of its potential COVID-19 treatment.
  • O2Micro International Limited (NASDAQ: OIIM) rose 19.2% to close at $4.03 after the company issued strong Q3 guidance.
  • Livent Corporation (NASDAQ: LTHM) shares climbed 18.1% to close at $11.29 after gaining around 6% on Friday.
  • Alpha and Omega Semiconductor Limited (NASDAQ: AOSL) jumped 17.7% to close at $15.38 after the company raised its Q1 sales guidance.
  • Fulgent Genetics, Inc. (NASDAQ: FLGT) gained 17.5% to close at $46.98. Fulgent Genetics recently announced partnership with Ohio Department of Rehabilitation and Correction for COVID-19 testing.
  • Protara Therapeutics, Inc. (NASDAQ: TARA) jumped 17.5% to close at $21.47. Perceptive Advisors, last week, disclosed a new 5.8% stake in the company.
  • Vir Biotechnology, Inc. (NASDAQ: VIR) climbed 17.3% to close at $39.11 after analysts at Bank of America initiated coverage on the stock with a Buy rating and announced a $55 price target.
  • Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) gained 16.8% to close at $49.97 after the company announced the completion of the first three dose escalation cohorts in Phase 1 study of its ARCT-810 for Ornithine Transcarbamylase Deficiency.
  • Beam Global (NASDAQ: BEEM) gained 16.3% to close at $17.44. Last month, Envision Solar announced rebranding as Beam Global.
  • American Well Corporation (NASDAQ: AMWL) jumped 16.3% to close at $33.00. Amwell recently reported expansion of partnership with Tyto Care for AI-powered and on-demand remote medical exams.
  • eXp World Holdings, Inc. (NASDAQ: EXPI) rose 15.9% to close at $50.68. eXp World. Last month, named James Huang as President of eXp Commercial.
  • Translate Bio, Inc. (NASDAQ: TBIO) surged 15.9% to close at $15.07 after Goldman Sachs initiated coverage on the stock with a Buy rating and announced a price target of $19 per share.
  • TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) gained 15.4% to close at $8.55. TOMI Environmental Solutions recently reported uplisting to the Nasdaq Capital Market.
  • Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) gained 15.2% to close at $16.41. Crinetics Pharmaceuticals, last month, received rare pediatric disease designation from the FDA for CRN04777 for the treatment of congenital hyperinsulinism.
  • Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) rose 14.8% to close at $13.86. Marinus Pharmaceuticals, last month, said it has satisfied the FDA's protocol-specific questions for the registrational Phase 3 trial of intravenous ganaxolone in refractory status epilepticus, allowing enrollment to begin in this clinical trial.
  • SunPower Corporation (NASDAQ: SPWR) gained 14.8% to close at $15.56. SunPower reported the creation of two new leadership roles to drive sustainability and diversity initiatives.
  • The St. Joe Company (NYSE: JOE) climbed 14.5% to close at $24.34.
  • ImmunoGen, Inc. (NASDAQ: IMGN) climbed 14.2% to close at $4.42 after the company's treatment for relapsed or refractory blastic plasmacytoid dendritic cell neoplasm was granted Breakthrough Therapy Designation by the FDA.
  • Solid Biosciences Inc. (NASDAQ: SLDB) rose 13.6% to close at $4.75 after jumping over 20% on Friday. Solid Biosciences, last week, said the FDA has lifted the clinical hold placed on the company's IGNITE DMD Phase 1/2 clinical trial.
  • HMS Holdings Corp. (NASDAQ: HMSY) rose 12.4% to close at $27.39. HMS Holdings is exploring feasible options while braving headwinds due to the Covid-19 pandemic, including a sale, according to Bloomberg.
  • Evogene Ltd. (NASDAQ: EVGN) gained 12.4% to close at $4.16 after declining over 8% on Friday.
  • GAN Limited (NYSE: GAN) gained 12.2% to close at $18.19 after the company announced a 10-year deal to provide Wynn Resorts with internet sports betting in Michigan.
  • JELD-WEN Holding, Inc. (NYSE: JELD) gained 11.8% to close at $26.18 after analysts at Wells Fargo upgraded the company's stock to Overweight and announced a $32 price target.
  • Leaf Group Ltd. (NYSE: LEAF) rose 11.1% to close at $6.00. Leaf Group said it expects preliminary Q3 sales growth of over 50% year-over-year.
  • XPeng Inc. (NYSE: XPEV) shares gained 10.2% to close at $20.04 after the company disclosed a record month and quarter in terms of electric vehicle deliveries.
  • CTI BioPharma Corp. (NASDAQ: CTIC) gained 9.7% to close at $3.28 after surging over 20% on Friday.
  • COMPASS Pathways plc (NASDAQ: CMPS) rose 8.9% to close at $40.10. COMPASS Pathways, last month, priced its IPO at $17 per share.
  • Pacific Biosciences of California, Inc. (NASDAQ: PACB) rose 8.8% to close at $12.74. JP Morgan, on Friday, upgraded the company's stock from Neutral to Overweight and announced a $15 price target.
  • Kosmos Energy Ltd. (NYSE: KOS) shares gained 8.7% to close at $1.12. Kosmos Energy reported closing of $200 million Gulf of Mexico facility.
  • Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) rose 7.1% to close at $605.08 after President Trump was treated with the company's experimental antibody cocktail.
  • Cincinnati Financial Corporation (NASDAQ: CINF) gained 5.5% to close at $82.03 after a panel of judges ruled insurance companies will not have to face business interruption claims related to COVID-19 on a consolidated basis.

Check out these big penny stock gainers and losers

Losers

  • Nam Tai Property Inc. (NYSE: NTP) shares tumbled 26.5% to close at $6.90 on Monday as the company raised $170 million through private placement transaction.
  • Synalloy Corporation (NASDAQ: SYNL) shares fell 18% to close at $4.69. Synalloy, last month, reported a loss for the second quarter.
  • Cinemark Holdings, Inc. (NYSE: CNK) dropped 17.4% to close at $8.33 after a competing movie theater operator, Regal Entertainment, closed all of its US locations due to a lack of big-ticket movies.
  • EPR Properties (NYSE: EPR) shares dropped 11.3% to close at $25.40.
  • Luby's, Inc. (NYSE: LUB) fell 11.2% to close at $2.86.
  • AMC Entertainment Holdings, Inc. (NYSE: AMC) fell 11.2% to close at $4.13 after a competing movie theater operator, Regal Entertainment, closed all of its US locations due to a lack of big-ticket movies.
  • Immunome, Inc. (NASDAQ: IMNM) dropped 10% to close at $12.10. Immunome, last week, priced its IPO at $12 per share.
  • RMG Acquisition Corp. (NYSE: RMG) shares fell 9.8% to close at $10.37. Romeo Power entered into a definitive merger agreement with RMG Acquisition.
  • DPW Holdings, Inc. (NYSE: DPW) shares dropped 9.7% to close at $2.04 after the company disclosed an offering of its common stock for $8.975 million.
  • Peabody Energy Corporation (NYSE: BTU) tumbled 8.8% to close at $2.18.
  • National CineMedia, Inc. (NASDAQ: NCMI) fell 8.5% to close at $2.57. Cineworld Group PLC-owned Regal Entertainment, the second-largest movie theatre chain in the U.S., is closing all its locations nationwide after movie studios delay big-ticket movies.
  • Liminal BioSciences Inc. (NASDAQ: LMNL) tumbled 8.3% to close at $10.13. Liminal Biosciences, last month, issued an update on progress on BLA for Ryplazim.
  • Ameri Holdings, Inc. (NASDAQ: AMRH) slipped 6.9% to close at $1.22.
  • The Marcus Corporation (NYSE: MCS) dropped 6.2% to close at $7.56. Marcus Hotels & Resorts recently appointed Andrew Flack as CCO.
  • Seelos Therapeutics, Inc (NASDAQ: SEEL) fell 5.6% to close at $0.9347. Seelos Therapeutics, last month, announced sponsored research agreement with Duke University for gene therapy studies of SLS-004 in Parkinson's disease.
  • Sintx Technologies, Inc. (NASDAQ: SINT) fell 5.6% to close at $2.01 after reporting a $75 million mixed securities shelf offering.
  • DraftKings Inc. (NASDAQ: DKNG) dipped 5.1% to close at $60.55 after the company announced a common stock offering of 32 million shares.
 

Related Articles (AMRH + AMC)

View Comments and Join the Discussion!

Posted-In: Movers From YesterdayNews Penny Stocks Pre-Market Outlook Markets Movers Trading Ideas